MR1 and rheumatoid arthritis: Furthermore, a previous study has shown that the CD3+ MR1-tetramer+ MAIT cell frequency is similar in HCs and patients with RA and that CD161 is reduced in early RA patients, indicating that the gating strategy of CD3+CD161+Vα7.2+ might be partially responsible for the reduction in MAIT cells (48).